Evidence map›Paper›PMID 39092531›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2024

Incidence of laboratory-confirmed influenza and RSV and associated presenteeism and absenteeism among healthcare personnel, Israel, influenza seasons 2016 to 2019.

Eduardo Azziz-Baumgartner, Avital Hirsch, Young M Yoo, Alon Peretz, David Greenberg, Yonat Shemer Avni, Aharona Glatman-Freedman, Michal Mandelboim, Adam MacNeil, Emily T Martin and 6 more

Abstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Eduardo Azziz-BaumgartnerUnited States Centers for Disease Control and Prevention (CDC), Atlanta, United States.
Avital HirschClalit Research Institute, Innovation Division, Clalit Health Services, Tel Aviv, Israel.
Young M YooUnited States Centers for Disease Control and Prevention (CDC), Atlanta, United States.
Alon PeretzRabin Medical Center, Clalit Health Services, Petah Tikva, Israel.
David GreenbergSoroka University Medical Center, Clalit Health Services, Beersheba, Israel.
Yonat Shemer AvniSoroka University Medical Center, Clalit Health Services, Beersheba, Israel.
Aharona Glatman-FreedmanSchool of Public Health, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
Michal MandelboimCentral Virology Laboratory, Ministry of Health, Tel-Hashomer, Israel.
Adam MacNeilUnited States Centers for Disease Control and Prevention (CDC), Atlanta, United States.
Emily T MartinSchool of Public Health, University of Michigan, Ann Arbor, Michigan, United States.
Gabriella Newes-AdeyiAbt Associates Inc., Atlanta, United States.
Mark ThompsonUnited States Centers for Disease Control and Prevention (CDC), Atlanta, United States.
Arnold S MontoSchool of Public Health, University of Michigan, Ann Arbor, Michigan, United States.
Ran D BalicerSchool of Public Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Be'er Sheva, Israel.
Min Z LevineUnited States Centers for Disease Control and Prevention (CDC), Atlanta, United States.
Mark A KatzClalit Research Institute, Innovation Division, Clalit Health Services, Tel Aviv, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundHealthcare personnel (HCP) are at high risk for respiratory infections through occupational exposure to respiratory viruses.AimWe used data from a prospective influenza vaccine effectiveness study in HCP to quantify the incidence of acute respiratory infections (ARI) and their associated presenteeism and absenteeism.MethodsAt the start and end of each season, HCP at two Israeli hospitals provided serum to screen for antibodies to influenza virus using the haemagglutination inhibition assay. During the season, active monitoring for the development of ARI symptoms was conducted twice a week by RT-PCR testing of nasal swabs for influenza and respiratory syncytial virus (RSV). Workplace presenteeism and absenteeism were documented. We calculated incidences of influenza- and RSV-associated ARI and applied sampling weights to make estimates representative of the source population.ResultsThe median age of 2,505 participating HCP was 41 years, and 70% were female. Incidence was 9.1 per 100 person-seasons (95% CI: 5.8-14.2) for RT-PCR-confirmed influenza and 2.5 per 100 person-seasons (95% CI: 0.9-7.1) for RSV illness. Each season, 18-23% of unvaccinated and influenza-negative HCP seroconverted. The incidence of seroconversion or RT-PCR-confirmed influenza was 27.5 per 100 person-seasons (95% CI: 17.8-42.5). Work during illness occurred in 92% (95% CI: 91-93) of ARI episodes, absence from work in 38% (95% CI: 36-40).ConclusionInfluenza virus and RSV infections and associated presenteeism and absenteeism were common among HCP. Improving vaccination uptake among HCP, infection control, and encouraging sick HCP to stay home are important strategies to reduce ARI incidence and decrease the risk of in-hospital transmission.

Indexed as

AbsenteeismHealth PersonnelInfluenza, HumanPresenteeismRespiratory Syncytial Virus InfectionsSeasonsAdultFemaleHemagglutination Inhibition TestsHumansIncidenceInfluenza VaccinesIsraelMaleMiddle AgedOccupational ExposureInfluenza Vaccinesabsenteeismfluhealthcare personnelincidenceIsraelpresenteeismRSV

Identifiers

PMID39092531
PMCPMC11295438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.